KASL慢性肝病肝纤维化评估无创检测临床实践指南。 - Suppr

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.

作者信息

Kim Mi Na, Han Ji Won, An Jihyun, Kim Beom Kyung, Jin Young-Joo, Kim Seung-Seob, Lee Minjong, Lee Han Ah, Cho Yuri, Kim Hee Yeon, Shin Yu Rim, Yu Jung Hwan, Kim Moon Young, Choi YoungRok, Chon Young Eun, Cho Eun Ju, Lee Eun Joo, Kim Sang Gyune, Kim Won, Jun Dae Won, Kim Seung Up

机构信息

Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

Yonsei Liver Center, Severance Hospital, Seoul, Korea.

出版信息

Clin Mol Hepatol. 2024 Sep;30(Suppl):S5-S105. doi: 10.3350/cmh.2024.0506. Epub 2024 Aug 19.

DOI:10.3350/cmh.2024.0506

PMID:39159947

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11493350/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1267/11493350/07e0843f0971/cmh-2024-0506f1.jpg

相似文献

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.

Clin Mol Hepatol. 2024 Sep;30(Suppl):S5-S105. doi: 10.3350/cmh.2024.0506. Epub 2024 Aug 19.

Noninvasive tests for liver disease, fibrosis, and cirrhosis: Is liver biopsy obsolete?

Cleve Clin J Med. 2010 Aug;77(8):519-27. doi: 10.3949/ccjm.77a.09138.

[Noninvasive Imaging Test to Assess Liver Fibrosis: Vibration-controlled Transient Elastography].

Korean J Gastroenterol. 2024 Nov 25;84(5):201-205. doi: 10.4166/kjg.2024.120.

Noninvasive Assessment of Liver Fibrosis.

Dig Dis. 2015;33(4):498-503. doi: 10.1159/000374097. Epub 2015 Jul 6.

Non-invasive diagnosis and follow-up of chronic liver disease.

Clin Res Hepatol Gastroenterol. 2022 Jan;46(1):101763. doi: 10.1016/j.clinre.2021.101763. Epub 2021 Jul 29.

A Single Test Combining Blood Markers and Elastography is More Accurate Than Other Fibrosis Tests in the Main Causes of Chronic Liver Diseases.

J Clin Gastroenterol. 2017 Aug;51(7):639-649. doi: 10.1097/MCG.0000000000000788.

[Non-invasive assessment of liver fibrosis].

Harefuah. 2015 Mar;154(3):204-7, 210, 209.

Noninvasive Markers to Assess Liver Fibrosis.

J Clin Gastroenterol. 2016 Jul;50(6):445-57. doi: 10.1097/MCG.0000000000000534.

Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease.

J Pediatr. 2014 Jan;164(1):186-8. doi: 10.1016/j.jpeds.2013.07.050. Epub 2013 Sep 21.

[Utility of Fibroscan in the evaluation of liver fibrosis].

Gastroenterol Hepatol. 2009 Jun-Jul;32(6):415-23. doi: 10.1016/j.gastrohep.2009.01.178. Epub 2009 May 27.

引用本文的文献

Listening to the spleen: a 100 Hz pulse toward a non-invasive way in assessing portal hypertension.

Hepatobiliary Surg Nutr. 2025 Aug 1;14(4):658-661. doi: 10.21037/hbsn-2025-294. Epub 2025 Jul 23.

Quantification of liver steatosis of metabolic dysfunction-associated steatotic liver disease based on body composition analysis.

Sci Rep. 2025 Aug 30;15(1):31982. doi: 10.1038/s41598-025-17396-1.

Performance of APRI and FIB-4 Scores Compared to FibroScan: A Cross-Sectional Study in a Black Sub-Saharan African Population.

Hepat Med. 2025 Jul 15;17:27-37. doi: 10.2147/HMER.S533064. eCollection 2025.

The association between modified cardiometabolic index with non-alcoholic fatty liver disease and liver fibrosis: a cross-sectional study.

BMC Gastroenterol. 2025 Apr 17;25(1):265. doi: 10.1186/s12876-025-03876-1.

The insight to history and trends of transient elastography for assessing liver fibrosis-a bibliometric analysis.

Quant Imaging Med Surg. 2025 Apr 1;15(4):2971-2986. doi: 10.21037/qims-24-2117. Epub 2025 Mar 13.

Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease.

Clin Mol Hepatol. 2025 Apr 4. doi: 10.3350/cmh.2024.1183.

KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025.

Clin Mol Hepatol. 2025 Feb;31(Suppl):S1-S31. doi: 10.3350/cmh.2025.0045. Epub 2025 Feb 19.

Age serves as the silent architect of FIB-4's precision in unveiling advanced hepatic fibrosis in MASLD with T2DM: Correspondence to letter to the editor on "Diagnostic accuracy of the fibrosis-4 index for advanced liver fibrosis in nonalcoholic fatty liver disease with type 2 diabetes: a systematic review and meta-analysis".

Clin Mol Hepatol. 2025 Apr;31(2):e152-e154. doi: 10.3350/cmh.2024.1160. Epub 2024 Dec 30.

Correspondence to editorial on "Prevalence of clinically significant liver fibrosis in the general population: A systematic review and meta-analysis".

Clin Mol Hepatol. 2025 Jan;31(1):e48-e51. doi: 10.3350/cmh.2024.0777. Epub 2024 Sep 11.

本文引用的文献

Predicting symptomatic post-hepatectomy liver failure in patients with hepatocellular carcinoma: development and validation of a preoperative nomogram.

Eur Radiol. 2023 Nov;33(11):7665-7674. doi: 10.1007/s00330-023-09803-w. Epub 2023 Jun 14.

Spleen Stiffness Measurement Across the Spectrum of Liver Disease Patients in Real-World Practice.

J Clin Exp Hepatol. 2023 May-Jun;13(3):414-427. doi: 10.1016/j.jceh.2022.12.015. Epub 2022 Dec 30.

NIS2+™, an optimisation of the blood-based biomarker NIS4® technology for the detection of at-risk NASH: A prospective derivation and validation study.

J Hepatol. 2023 Sep;79(3):758-767. doi: 10.1016/j.jhep.2023.04.031. Epub 2023 May 22.

Antiviral therapy substantially reduces HCC risk in patients with chronic hepatitis B infection in the indeterminate phase.

Hepatology. 2023 Nov 1;78(5):1558-1568. doi: 10.1097/HEP.0000000000000459. Epub 2023 May 16.

Fibrosis-4 Index Predicts Long-Term All-Cause, Cardiovascular and Liver-Related Mortality in the Adult Korean Population.

Clin Gastroenterol Hepatol. 2023 Dec;21(13):3322-3335. doi: 10.1016/j.cgh.2023.04.026. Epub 2023 May 8.

Clinical Significance of the Mac-2 Binding Protein Glycosylated Isomer as a Surrogate Marker of Graft Fibrosis After Pediatric Liver Transplantation.

Transplant Proc. 2023 May;55(4):930-933. doi: 10.1016/j.transproceed.2023.03.053. Epub 2023 Apr 30.

Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission.

JGH Open. 2023 Mar 25;7(4):272-277. doi: 10.1002/jgh3.12865. eCollection 2023 Apr.

An individual patient data meta-analysis to determine cut-offs for and confounders of NAFLD-fibrosis staging with magnetic resonance elastography.

J Hepatol. 2023 Sep;79(3):592-604. doi: 10.1016/j.jhep.2023.04.025. Epub 2023 Apr 29.

Staging liver fibrosis in patients with chronic hepatitis B using two-dimensional shear wave elastography based on histopathological findings: a prospective multicenter study.

Quant Imaging Med Surg. 2023 Apr 1;13(4):2376-2387. doi: 10.21037/qims-22-831. Epub 2023 Mar 6.

Fibrosis-4 index, a predictor for prognosis of hepatocellular carcinoma patients after curative hepatectomy even in hepatitis B virus dominant populations.

Ann Surg Treat Res. 2023 Apr;104(4):195-204. doi: 10.4174/astr.2023.104.4.195. Epub 2023 Mar 31.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

KASL clinical practice guidelines for noninvasive tests to assess liver fibrosis in chronic liver disease.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献